Tectonic Therapeutic, Inc.
TECX Nasdaq
SEC CIK 1681087
Follow Tectonic Therapeutic
Weekly email: filings, results
Net income
−$21.3M
−12.1% vs same quarter last year
EPS, diluted
−$1.08
−5.9% vs same quarter last year
Operating cash flow
−$14.9M
+16.3% vs same quarter last year
Operating income
−$23.5M
−7.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$74.2B |
| FY24 | −$58B |
| FY23 | −$42.8B |
| FY22 | −$105.9M |
| FY21 | −$119.1M |
| FY20 | −$119.7M |
| FY19 | −$73M |
| FY18 | −$46.4M |
| FY17 | −$18.6M |
| FY16 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$60.3M |
| FY24 | −$59.2M |
| FY23 | −$41M |
| FY22 | −$97.5M |
| FY21 | −$100.5M |
| FY20 | −$100M |
| FY19 | −$69.3M |
| FY18 | −$39.5M |
| FY17 | −$16.8M |
| FY16 | - |